Regarding the disability assessment in patients with chronic obstructive pulmonary disease using International Classification of Functioning, Disability and Health. Purpose: To optimize the assessment of disability in patients with chronic obstructive pulmonary disease using the International Classification of Functioning, Disability and Health. Material and methods: Analysis of scientific publications selected from medical information databases (MEDLINE, EMBASE, etc.). Results and conclusion: in order to optimize the approach to disability in patients with chronic obstructive pulmonary disease using the International Classification of Functioning, Disability and Health (ICF): the literature was analyzed by specialty, selected from medical databases (Medline, etc.); studied with the categories included in the ICF sets recommended by the WHO and proposed by a number of authors who apply them to patients with COPD and other chronic obstructive pulmonary disease; the topicality of the problem, the unresolved objectives, the perspectives of further scientific research and the relevance of their conclusions for the tasks of medical and social expertise and in the rehabilitation of patients with chronic obstructive pulmonary disease were reflected.
The term nontuberculous mycobacteria (NTM) includes different species of mycobacteria, other than Mycobacterium tuberculosis complex (M. bovis, M. africanum, M. microti, M. canetti, M. caprae, M. pinnipedii, M. suricatta, M. mungi) and other than those that cause leprosy (M. leprae, M. lepromatosis). The rate of lung infection with NTM increases with age and varies considerably in different countries. NTM are opportunistic pathogens that can cause the disease, especially in immunocompromised patients or in those with preexisting lung disease. The decision to initiate the treatment is based on an assessment of the potential risks and benefits, individually for each patient. The aim of the treatment is to liquidate/ improve the clinical and functional manifestations, to reduce the lung lesions and to restore work capacity. The treatment of patients with mycobacteriosis is a complex one (polychemotherapy, if necessary — surgical treatment etc.), long-term, under direct observation, administered in the hospital and/or at home. The treatment regimen is chosen depending on the species involved, radiological picture, comorbidities, drug sensitivity etc.
Nosological structure and dynamics of adult population disability in the Republic of Moldova Purpose. To study the current nosological structure and dynamics of the general and primary disability of the adult population in the Republic of Moldova. Materials and methods. Analysis of official statistics data (statistica.md, cnddcm.msmps.gov.md) for 2015-2019. Results. In 2015-2019, there was a wave-like change in the number of adults recognized as disabled for the first time in the republic and its increase in 2019 by ⅔ relative to 2018 (13713 and 8350, respectively). The structure of general disability, taking into account the degree of severity, changed little during the study period. In 2019, it was dominated by moderate disability - 47.1%; severe and severe disability was established in 38.0% and 14.9% of cases, respectively. The nosological structure of disability in general also changed little. In 2019, the main causes of disability in the adult population were tumors 20.0%, cardiovascular diseases - 18%, and diseases of the musculoskeletal system and connective tissue - 14.6%. At the same time, in 2019, respiratory diseases were the cause of disability in 2.7% of cases, or 1.4 times more often compared to 2018. Conclusions. In recent years, the main causes of disability in the republic are tumors, cardiovascular diseases, diseases of the musculoskeletal system and connective tissue, the proportion of respiratory diseases does not exceed 2.7%. In the structure of disability, moderate disability prevails.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.